InflaRx (IFRX) Non-Current Assets (2016 - 2026)

InflaRx's (IFRX) quarterly Non-Current Assets came in at $1.7 million in Q1 2026, up 19.61% year-on-year from $1.5 million in Q1 2025, and down 5.12% quarter-over-quarter from $1.8 million in Q4 2025.

InflaRx (IFRX) Non-Current Assets (2016 - 2026) Analysis & Trends

InflaRx has disclosed Non-Current Assets across 11 years of filings, most recently posting $1.7 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $1.7 million, up 19.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 19.61% YoY), and the FY2025 annual result was $1.8 million, down 60.5% from the prior year.
  • Non-Current Assets came in at $1.7 million for Q1 2026 at InflaRx, down from $1.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $22.6 million in Q2 2023 to a low of $1.5 million in Q1 2025.
  • The 5-year median for Non-Current Assets is $4.5 million (2024), against an average of $6.0 million.
  • Across the five-year window, Non-Current Assets tumbled 93.0% in 2022 and jumped 745.61% in 2023, its largest moves.
  • InflaRx's Non-Current Assets stood at $5.1 million in 2022, then jumped by 127.04% to $11.6 million in 2023, then tumbled by 59.66% to $4.7 million in 2024, then tumbled by 60.5% to $1.8 million in 2025, then declined by 5.12% to $1.7 million in 2026.
  • The last three Non-Current Assets figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 62,953.78
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4.56 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 30.30 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.26 Bn 94.26 Bn - 39.71 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 1.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.75 Mn
Dec 31, 2025 1.84 Mn
Sep 30, 2025 1.98 Mn
Jun 30, 2025 8.23 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 4.66 Mn
Sep 30, 2024 6.66 Mn
Jun 30, 2024 1.87 Mn
Mar 31, 2024 4.48 Mn
Dec 31, 2023 11.56 Mn
Sep 30, 2023 2.12 Mn
Jun 30, 2023 22.59 Mn
Mar 31, 2023 10.63 Mn
Dec 31, 2022 5.09 Mn
Sep 30, 2022 2.40 Mn
Jun 30, 2022 2.67 Mn
Mar 31, 2022 12.77 Mn
Dec 31, 2021 33.70 Mn
Sep 30, 2021 34.34 Mn
Jun 30, 2021 3.41 Mn